About US
Contact us
-
Chinese authorities say GSK employees confess to briberyLast month GSK fired R&D chief in China for alleged misconduct GlaxoSmithKline ($GSK) has for weeks been saying that it could find no evidence to confirm allegations that any of its employees inC2013/7/12
-
BMS, Pfizer say FDA to review Eliquis for new useThe FDA will considerEliquisfor a new indication, one which Pfizer ($PFE) and partner Bristol-Myers Squibb ($BMY) hope can help the blood thinner hit the sales potential analysts predicted for the dru2013/7/12
-
Pharma, FDA still lagging in post-marketing safety researchThe good news: Drugmakers are wrapping up more post-marketing safety studies, now that the FDA can crack the whip. More good news: Companies got to work on a bigger proportion of the studies required.2013/7/11
-
Risperdal plaintiff's lawyer demands sealed J&J docs from FDAIf you don't succeed in court, try the FDA. That's the approach of a Philadelphia lawyer who wants to make someRisperdaldata public, but is barred from doing so by a federal judge's order. As thePhil2013/7/11
-
Data fraud allegedly delayed FDA nod for Pfizer-BMS drug EliquisData errors and alleged fraud at clinical trial sites in China held up approval of Pfizer ($PFE) and Bristol-Myers Squibb's ($BMY) clot-fighting drugEliquis, according to media reports. The allegation2013/7/10
-
Vivus hooks up with Menarini to hawk ED pill Spedra in $121M dealIf you've been following the Vivus ($VVUS) proxy fight, you know the company's lack of marketing muscle has been a big point of contention. Proxy challengerFirst Manhattanhas aired its grievances loud2013/7/10
-
Vivus, FMC both tout proxy advisers' support for board nomineesIf Vivus shareholders were looking for some unqualified advice for their proxy votes, they're disappointed. Proxy advisers have now weighed in on the fight for control at Vivus, and the counsel is a m2013/7/9
-
GlaxoSmithKline faces new allegations over China Botox salesGlaxoSmithKline ($GSK) is again scrambling to put out fires, asThe Wall Street Journalhas published new allegations suggesting that GSK employees paid Chinese doctors bribes to prescribe drugs,Botoxin2013/7/9
-
Lilly's Lechleiter returns to CEO suite after surgeryEli Lilly ($LLY) CEOJohn Lechleiteris back on the job. Two months ago, Lechleiter bowed out for surgery on a dilated aorta, handing over the reins to CFODerica Rice. Now, the company says he has the g2013/7/9
-
Roche bids for broad use of HPV test to screen for cervical cancerRoche ($RHHBY) is aiming to make itshuman papillomavirustest a first-line diagnostic forcervical cancer, with a new FDA application for the Cobas HPV as a substitute for Pap tests. Currently the test2013/7/8